Results 221 to 230 of about 188,238 (387)

Fentanyl in the US heroin supply: A rapidly changing risk environment.

The International journal on drug policy, 2017
D. Ciccarone
semanticscholar   +1 more source

Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle

Addiction, EarlyView.
Abstract The opioid overdose epidemic remains a critical public health crisis. In recent years, synthetic opioids like fentanyl and nitazenes, have driven a sharp rise in deaths. Naloxone, an opioid receptor antagonist, has been established as a key intervention for reversing opioid overdoses and saving lives.
Mariana Gonzalez Utrilla, Edward Chesney, Joanne Neale, Nicola Metrebian, Nicola Kalk, Arne Kristian Skulberg, Paul Dietze, Martin Smith, John Strang   +8 more
wiley   +1 more source

STUDIES OF DRUGS GIVEN BEFORE ANAESTHESIA XXII: PHENOPERIDINE AND FENTANYL, ALONE AND IN COMBINATION WITH DROPERIDOL

, 1970
J.D. MORRISON
openalex   +1 more source

Effects of Fentanyl on Baroreceptor Reflex Control of Heart Rate in Newborn Infants [PDF]

, 1988
I. Murat, Jean‐Claude Levron, Alain Berg, Claude Saint-Maurice   +3 more
openalex   +1 more source

Development and evaluation of a machine learning model to predict acute care for opioid use disorder among Medicaid enrollees engaged in a community‐based treatment program

Addiction, EarlyView.
Abstract Aims To develop machine‐learning algorithms for predicting the risk of a hospitalization or emergency department (ED) visit for opioid use disorder (OUD) (i.e. OUD acute events) in Pennsylvania Medicaid enrollees in the Opioid Use Disorder Centers of Excellence (COE) program and to evaluate the fairness of model performance across racial ...
Lingshu Xue, Ruofei Yin, Evan S. Cole, Wei‐Hsuan Lo‐Ciganic, Walid F. Gellad, Julie Donohue, Lu Tang   +6 more
wiley   +1 more source

EVALUATION AND COMPARISON OF RECOVERY TIME FROM ALFENTANIL AND FENTANYL FOR SHORT SURGICAL PROCEDURES [PDF]

, 1984
S. K. Kallar, R. L. Keenan
openalex   +1 more source

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

The Journal of Dermatology, EarlyView.
Yoshihide Asano, Jun Asai, Takayuki Ishii, Yohei Iwata, Masanari Kodera, Chie Miyabe, Akihiko Uchiyama, Youichi Ogawa, Ken Okamura, Mari Kishibe, Yuta Koike, Yorihisa Kotobuki, Noriki Fujimoto, Takuya Miyagi, Yukie Yamaguchi, Ayumi Yoshizaki, Reiko Omori, Takeshi Nakanishi, Hiroshi Fujiwara, Takeo Maekawa, Sei‐ichiro Motegi, Yuichiro Yoshino, Minoru Hasegawa, Manabu Fujimoto, Takao Tachibana, Wound, Pressure Ulcer, and Burn Guidelines Drafting Committee (connective tissue disease/vasculitis group)   +27 more
wiley   +1 more source

Elevated rate of suicide risk in individuals with opioid use disorder

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Few studies have longitudinally investigated suicide risk (SR) in opioid use disorder (OUD). This investigation administered three screening tools to individuals with OUD to compare rates of and variables associated with SR over 12 months.
Max Spaderna, Elana Rosenthal, Sun Jung Kang, Rahwa Eyasu, Emade Ebah, Onyinyechi Ogbumbadiugha, Phyllis Bijole, Amelia Cover, Ashley Davis, Meredith Zoltick, Sita Kottilil, Julia Mount, Catherine Gannon, Jasmine Stevens, Grace Garrett, Meghan Derenoncourt, Tina Liu, Lisa Horowitz, Maryland Pao, Sarah Kattakuzhy   +19 more
wiley   +1 more source

INFLUENCE OF FENTANYL ON THE CHRONOTROPIC RESPONSE OF ISOLATED RABBIT ATRIA TO CHOLINERGIC AND ADRENERGIC STIMULATION

, 1978
Yoshio Hatano, Noboru Toda
openalex   +1 more source

Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage, Becky Bishop, Vikki Mangano, Baher Mankabady   +3 more
wiley   +1 more source